Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children’s Cancer Group

Hiroaki Miyahara(Aichi Medical University), Yasushi Iwasaki(Aichi Medical University), Yonehiro Kanemura(National Institute of Biomedical Innovation, Health and Nutrition), Yuichi Riku(Aichi Medical University), Makiko Yoshida(Kobe Children's Hospital), Mari Yoshida(Aichi Medical University), Michio Ozeki(Gifu University), Takashi Taga(Erasmus MC), Manabu Natsumeda(Niigata University), Kenji Ihara(Oita University), Kai Yamasaki(Osaka City General Hospital), Yuki Naruke(Chiba Hospital), Tomoko Shofuda(Osaka National Hospital), Junichi Hara(The University of Osaka), Souichi Suenobu(Oita University), Yoshiki Arakawa(Kyoto Prefectural University of Medicine), Naoki Okada(Tokai University), Ema Yoshioka(Osaka National Hospital), Akio Akagi(Aichi Medical University), Yukihiko Fujii(Niigata University), Ryo Ando(Chiba Hospital), Daiichiro Hasegawa(Kobe Children's Hospital), Tsukasa Sakaida(Chiba Cancer Center), Yuya Sato(National Institute of Advanced Industrial Science and Technology), Hiroyoshi Watanabe(Tokushima University), Akiyoshi Kakita(Niigata University), Junichi Yoshimura(Niigata University), Wataru Oohashi(Aichi Medical University Hospital)
Brain Tumor Pathology
March 11, 2021
Cited by 3


Related Papers